Literature DB >> 20858165

Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins.

Shakila B Rizwan1, Ben J Boyd, Thomas Rades, Sarah Hook.   

Abstract

IMPORTANCE OF THE FIELD: Self-assembling lipid-based liquid crystalline systems are a broad and active area of research. Of these mesophases, the cubic phase with its highly twisted bilayer and two non-intersecting water channels has been investigated extensively for drug delivery. The cubic phase has been shown to accommodate and control the release of drugs with varying physicochemical properties. Also, the lipids used to prepare these delivery systems are generally cheap, safe and biodegradable, making these systems highly attractive. Early research investigating the potential of cubic phases as delivery systems showed that several peptides or proteins entrapped within these gel-based systems showed retarded release. Furthermore, entrapment within the cubic phase protected the selected peptide or protein from chemical and physical degradation with its native confirmation and bioactivity retained. AREAS COVERED IN THIS REVIEW: In this review, the literature pertaining to the delivery of various bioactives from cubic liquid crystalline phases is examined, with a particular focus on peptides and proteins. The scope and limitations of the cubic phases in this respect and the future of cubic liquid crystalline systems as sustained delivery systems are highlighted. WHAT THE READER WILL GAIN: The reader will be able to gain an understanding of the properties of the bicontinuous cubic phase and how its structural attributes make these systems desirable for sustained delivery of bioactives, in particular peptides and proteins, but also how these same structural properties have hindered progress towards clinical applications. Current strategies to overcome these issues will also be discussed. TAKE HOME MESSAGE: The bicontinuous cubic phase offers great potential in the field of peptide and protein delivery, but limited research in this area precludes definite conclusions to its future in this respect.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20858165     DOI: 10.1517/17425247.2010.515584

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  10 in total

Review 1.  Liquid Crystalline Phases for Enhancement of Oral Bioavailability.

Authors:  Xingwang Zhang; Wei Wu
Journal:  AAPS PharmSciTech       Date:  2021-02-22       Impact factor: 3.246

2.  A macroscopic H+ and Cl- ions pump via reconstitution of EcClC membrane proteins in lipidic cubic mesophases.

Authors:  Chiara Speziale; Livia Salvati Manni; Cristina Manatschal; Ehud M Landau; Raffaele Mezzenga
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-16       Impact factor: 11.205

3.  Structural insights into the cubic-hexagonal phase transition kinetics of monoolein modulated by sucrose solutions.

Authors:  Caleb W Reese; Zachariah I Strango; Zachary R Dell; Stephanie Tristram-Nagle; Paul E Harper
Journal:  Phys Chem Chem Phys       Date:  2015-03-11       Impact factor: 3.676

4.  Phytantriol Based "Stealth" Lyotropic Liquid Crystalline Nanoparticles for Improved Antitumor Efficacy and Reduced Toxicity of Docetaxel.

Authors:  Sanyog Jain; Neha Bhankur; Nitin K Swarnakar; Kaushik Thanki
Journal:  Pharm Res       Date:  2015-05-13       Impact factor: 4.200

5.  Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes.

Authors:  Yogita Patil-Sen; Amin Sadeghpour; Michael Rappolt; Chandrashekhar V Kulkarni
Journal:  J Vis Exp       Date:  2016-02-19       Impact factor: 1.355

Review 6.  NMR spectroscopy of lipidic cubic phases.

Authors:  Sunnia Rajput; Shenggen Yao; David W Keizer; Marc-Antoine Sani; Frances Separovic
Journal:  Biophys Rev       Date:  2021-11-11

Review 7.  Factors affecting the structure of lyotropic liquid crystals and the correlation between structure and drug diffusion.

Authors:  Yiming Huang; Shuangying Gui
Journal:  RSC Adv       Date:  2018-02-13       Impact factor: 4.036

8.  Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.

Authors:  Zhiwen Yang; Yinhe Tan; Meiwan Chen; Linghui Dian; Ziyun Shan; Xinsheng Peng; Chuanbin Wu
Journal:  AAPS PharmSciTech       Date:  2012-10-23       Impact factor: 3.246

Review 9.  Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy.

Authors:  Chelsea R Thorn; Nicky Thomas; Ben J Boyd; Clive A Prestidge
Journal:  Drug Deliv Transl Res       Date:  2021-03-05       Impact factor: 4.617

10.  Self-assembly of glycerol monooleate with the antimicrobial peptide LL-37: a molecular dynamics study.

Authors:  R Innocenti Malini; M Zabara; M Gontsarik; K Maniura-Weber; R M Rossi; F Spano; S Salentinig
Journal:  RSC Adv       Date:  2020-02-26       Impact factor: 4.036

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.